Prochorec-Sobieszek Monika, Szufladowicz Ewa, Szaroszyk Włodzimierz, Wagner Teresa, Loukas Marios
Department of Pathology, Institute of Rheumatology, Warsaw, Poland.
Med Sci Monit. 2005 Aug;11(8):CS45-8. Epub 2005 Jul 25.
Primary amyloid light-chain (AL) amyloidosis results from plasma cell dyscrasia. Fibrillar deposits of monoclonal immunoglobulin light chains are present in various organs, especially in the heart. The patients suffer from fatal cardiac dysfunction.
We report the case of a 54-year-old man with symptoms of cardiac arrhythmia which was refractory to conventional treatment and ablations. At a later stage of his disease, the diagnosis of AL amyloidosis associated with monoclonal gammapathy of uncertain significance was established. Echocardiography, electrocardiography, serum immunofixation studies, abdominal fat aspirate biopsy, and bone marrow biopsy indirectly confirmed the diagnosis of cardiac amyloidosis. The patient died.
The diagnosis of AL cardiac amyloidosis is difficult, the prognosis always serious, the available therapy limited, and the mortality high.
原发性轻链(AL)淀粉样变性由浆细胞发育异常引起。单克隆免疫球蛋白轻链的纤维状沉积物存在于各个器官中,尤其是心脏。患者会出现致命的心脏功能障碍。
我们报告了一名54岁男性的病例,该患者患有心律失常症状,常规治疗和消融治疗均无效。在疾病后期,确诊为与意义未明的单克隆丙种球蛋白病相关的AL淀粉样变性。超声心动图、心电图、血清免疫固定电泳研究、腹部脂肪抽吸活检和骨髓活检间接证实了心脏淀粉样变性的诊断。患者死亡。
AL型心脏淀粉样变性诊断困难,预后总是很严重,可用治疗方法有限,死亡率高。